Boundless Bio, Inc.Boundless Bio, Inc.Boundless Bio, Inc.

Boundless Bio, Inc.

No trades
See on Supercharts

BOLD fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F. Cravatt, and Jonathan E. Lim on April 10, 2018 and is headquartered in San Diego, CA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
BOLD has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company